Search Results 81-90 of 23906 for pharmacogenetics
About this study. The purpose of this study is to determine whether the implementation of pre-emptive PGx[HSR1] testing of a panel of clinically relevant ...
... pharmacogenetic testing. Transplant infectious diseases. Dr. Cummins partners with other researchers at Mayo Clinic to improve the diagnosis and treatment ...
Alzheimer's disease (AD) is likely influenced by the interaction of many genetic and environmental factors, some of which may act by influencing brain gene ...
Application and admissions information for the PGY-2 Clinical Pharmacogenomics Residency at Mayo Clinic in Rochester, Minnesota.
Read frequently asked questions and answers about genetic testing and genetic testing results from the Mayo Clinic Center for Individualized Medicine.
Pharmacogenetics of FGIDs. Significance to patient care. FGIDs are very common — they account for more than half of referrals to gastroenterology clinics ...
Learn how pharmacists play a key role in clinical research at Mayo Clinic College of Medicine and Science, and discover our postgraduate pharmacy ...
... pharmacogenetics and biological effects of agents in tumor cells in situ, before transitioning these treatments to appropriate disease-specific clinical ...
Our investigators have made a number of key advances in this research area, including: Studying the pharmacogenetics of tamoxifen in secondary analyses of ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can go twice as far to fight cancer.